MedPath

Subarachnoid haemorrhage (SAH): brain damage, cognitive and behavioral functioning as predictors of recovery.

Recruiting
Conditions
intracranial haemorrhage
subarachnoid haemorrhage
10002363
Registration Number
NL-OMON54915
Lead Sponsor
niversitair Medisch Centrum Groningen
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
235
Inclusion Criteria

1. A SAH patient, the diagnosis being based on clinical features in combination
with CT angiography (CTA) or digital subtraction angiography (DSA).
2. The patient must be able to understand the instructions of the
neuropsychological assessment and be mentally and physically able to undergo
the research activities; this will be assessed in a consultation between the
treating doctor (neurosurgeon) and researcher (neuropsychologist).
3. Sufficient knowledge of the Dutch language.
4. Age 18 or older

Exclusion Criteria

A limited physical and/or cognitive condition which makes it impossible for
patients to undergo the neuropsychological assessment and MRI.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary outcome measure consists of the score on the Impact on<br /><br>Participation and Autonomy (IPA) (Cardol, 2005) questionnaire 1 year after SAH.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>- The score on the IPA 2 years after SAH;<br /><br>- The score on the mRS 1 and 2 years after SAH;<br /><br>- Performance on neuropsychological tests (intelligence, memory, attention,<br /><br>mental speed, language, visuoconstruction skills, executive functions and<br /><br>social cognition);<br /><br>- Scores on questionnaires (complaints, fatigue, anxiety/depression, stress,<br /><br>coping, personality, behavior, quality of life)<br /><br>- Neuro-imaging outcomes (RS-fMRI, DWI, VBM)<br /><br>o ASL/VAI: cerebral blood flow (CBF), cerebral blood volume (CBV), vessel size,<br /><br>oxygen saturation, vessel architecture<br /><br>o DTI: fractional anisotropy (FA) en apparent diffusion coefficient (ADC)<br /><br>o SWI/QSM: affected tissue volume en hemosiderosis volume<br /><br>o Synthetic MRI: quantitative T1, T2, proton density (PD) values.</p><br>
© Copyright 2025. All Rights Reserved by MedPath